Hu, Zexuan
Sun, Peng
George, Ajit
Zeng, Xiangling
Li, Mengyan
Lin, Tsen-Hsuan
Ye, Zezhong
Wei, Xinhua
Jiang, Xinqing
Song, Sheng-Kwei
Yang, Ruimeng https://orcid.org/0000-0003-2768-9429
Funding for this research was provided by:
National Natural Science Foundation of China (81971574)
Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515220060)
Special Fund for the Construction of High-level Key Clinical Specialty (Medical Imaging) in Guangzhou, Guangzhou Key Laboratory of Molecular Imaging and Clinical Translational Medicine (202201020376)
National Institutes of Health (R01-NS047592, P01-NS059560, U01-EY025500)
National Multiple Sclerosis Society (RG 1701-26617)
Article History
Received: 31 August 2022
Revised: 13 March 2023
Accepted: 30 March 2023
First Online: 12 July 2023
Declarations
:
: The scientific guarantor of this publication is Dr. Ruimeng Yang.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: Ningning Wang kindly provided statistical advice for this manuscript.
: Written informed consent was obtained from all participants.
: Institutional review board approval was obtained.
: • prospective
: • multicenter study